Final Analysis of Camrelizumab Plus Chemotherapy for Untreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma: the ESCORT-1st Trial
Med(2024)
关键词
camrelizumab,advanced or metastatic esophageal squamous cell carcinoma,first-line treatment,overall survival,prediction,phase 3 trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要